Already at an early stage in the development process, a potential additional benefit must be identified, which is then presented to the authorities and health insurance companies in the context of the market launch by means of a benefit dossier to show the value of the drug or medical device. The experts in this area must combine business knowledge with scientific expertise and have a thorough knowledge of the healthcare market and its political and legal framework. In addition, they must be able to negotiate effectively and confidently during the market launch process as well as in subsequent price negotiations. The ability to work with other departments across divisions rounds off the complex requirements profile for these positions.
You can book an appointment with Max Slevogt right here: book an appointment